Tecentriq (atezolizumab) mellékhatások, interakciók, felhasználások és gyógyszer-lenyomatok - Egészség 2026
oldmedic.com
Tecentriq (atezolizumab) mellékhatások, interakciók, felhasználások és gyógyszer-lenyomatok - Egészség 2026
A Tecentriq-rel (atezolizumab) kapcsolatos gyógyszerinformációk tartalmaznak gyógyszerképeket, mellékhatásokat, gyógyszerkölcsönhatásokat, használati utasításokat, a túladagolás tüneteit és az elkerülendő lehetőségeket.
Aug 23, 2019
Atezolizumab Side Effects
Tecentriq (Atezolizumab) Nebenwirkungen, Wechselwirkungen, Verwendungen und Arzneimittelabdruck - Gesundheit 2026
Tecentriq (Atezolizumab) Nebenwirkungen, Wechselwirkungen, Verwendungen und Arzneimittelabdruck - Gesundheit 2026
oldmedic.com
Aug 24, 2019
Immune Adverse Events from Atezolizumab + Bevacizumab in Liver Cancer Patients | Oncotarget
2:14
Immune Adverse Events from Atezolizumab + Bevacizumab in Liver Cancer Patients | Oncotarget
YouTubeOncotarget
110 views9 months ago
Immunotherapy: What Are the Side Effects?
Immunotherapy: What Are the Side Effects?
WebMDStephanie Booth
Feb 29, 2024
Top videos
【中外製薬】テセントリク（アテゾリズマブ）について詳しく紹介！！｜MediCare｜医療と介護の総合メディア
3:42
【中外製薬】テセントリク（アテゾリズマブ）について詳しく紹介！！｜MediCare｜医療と介護の総合メディア
hitouch-medical.com
Nov 9, 2018
Sangeetha Palakurthi on FDA Approval of Atezolizumab in NSCLC | OncLive
Sangeetha Palakurthi on FDA Approval of Atezolizumab in NSCLC | OncLive
onclive.com
Oct 19, 2016
Atezolizumab Bevacizumab in Treatment-Naive mRCC | OncLive
Atezolizumab Bevacizumab in Treatment-Naive mRCC | OncLive
onclive.com
Oct 4, 2017
Atezolizumab Cancer Treatment
CBS News Live
1:22
CBS News Live
CBS NewsAshley Welch
May 18, 2016
Lurbinectedin + Atezolizumab as First-Line Maintenance Treatment in Patients With Extensive-Stage Small Cell Lung Cancer: Primary Results of the Phase 3 IMforte Trial | OncLive
Lurbinectedin + Atezolizumab as First-Line Maintenance Treatment in Patients With Extensive-Stage Small Cell Lung Cancer: Primary Results of the Phase 3 IMforte Trial | OncLive
onclive.com
2 weeks ago
Data From the AtTEnd: Study: Atezolizumab Plus Carboplatin and Paclitaxel for Treatment of Advanced Endometrial Cancer | OncLive
6:35
Data From the AtTEnd: Study: Atezolizumab Plus Carboplatin and Paclitaxel for Treatment of Advanced Endometrial Cancer | OncLive
onclive.com
Dec 11, 2023
【中外製薬】テセントリク（アテゾリズマブ）について詳しく紹介！！｜MediCare｜医療と介護の総合メディア
3:42
【中外製薬】テセントリク（アテゾリズマブ）について詳しく紹介！！…
Nov 9, 2018
hitouch-medical.com
Sangeetha Palakurthi on FDA Approval of Atezolizumab in NSCLC | OncLive
Sangeetha Palakurthi on FDA Approval of Atezolizumab in NSCL…
Oct 19, 2016
onclive.com
Atezolizumab Bevacizumab in Treatment-Naive mRCC | OncLive
Atezolizumab Bevacizumab in Treatment-Naive mRCC | OncLive
Oct 4, 2017
onclive.com
Pharma Mar says Swiss Medical Authority approves Zepzelca and Atezolizumab combination for lung cancer
Pharma Mar says Swiss Medical Authority approves Zepzelca and …
3 months ago
marketscreener.com
Dr. Levy on the Future of Atezolizumab in NSCLC | OncLive
Dr. Levy on the Future of Atezolizumab in NSCLC | OncLive
Nov 11, 2022
onclive.com
Atezolizumab After Adjuvant Chemotherapy in Resectable NSCLC | OncLive
Atezolizumab After Adjuvant Chemotherapy in Resectable NSC…
4 weeks ago
onclive.com
ATOMIC Backs Atezolizumab+FOLFOX in dMMR Colon Cancer
ATOMIC Backs Atezolizumab+FOLFOX in dMMR …
6 months ago
medscape.com
ASCO® 2025 Insights Plenary Session: Ph3 ATOMIC Trial - Adju…
157 views9 months ago
vumedi.com
ASCO 2021 Highlights From IMpower 010 on Resected Stage I…
591 viewsJul 1, 2021
vumedi.com
12:40
Real-world comparison of the efficacy and safety of atezolizuma…
Dec 17, 2024
onclive.com
2:02
Dr Li on the Casdozokitug/Atezolizumab/Beva…
Feb 28, 2025
onclive.com
7:10
The STRIDE Regimen vs Atezolizumab/Bevacizumab: Selec…
Oct 25, 2024
onclive.com
6:35
Data From the AtTEnd: Study: Atezolizumab Plus Carboplatin an…
Dec 11, 2023
onclive.com
Dr Kaseb on the Investigation of Adjuvant Atezolizumab and Bevac…
Apr 21, 2023
onclive.com
FDA Approval of Durvalumab for Bladder Cancer
Apr 22, 2017
onclive.com
FDA Approval of Durvalumab for Advanced Bladder Cancer | OncLive
Apr 22, 2017
onclive.com
Pharma Mar receives $50 mln from Jazz Pharmaceuticals for FDA app…
4 months ago
marketscreener.com
Dr. Hamilton on FDA Approval of Atezolizumab/Nab-Paclitaxel in TN…
Mar 8, 2019
onclive.com
Dr. Lynce on FDA Approval of Atezolizumab/Nab-Paclitaxel in TN…
Feb 12, 2020
onclive.com
Dr. Mittendorf on FDA Approval of Frontline Atezolizumab/Nab-Paclit…
2 months ago
onclive.com
1:12
How Atezolizumab May Help Mesothelioma Patients
2 months ago
YouTubeSurviving Mesothelioma
Trending in Oncology: Fast-Track ADCs, Perioperative IO and more
3 months ago
YouTubeLucidQuest
4:01
U.S. Food and Drug Administration - FDA D.I.S.C.O. Burst Edition: FDA …
3 weeks ago
Internet ArchiveGrumpy Systems
1:48
🏆 A "historic achievement" for the majority of patients with mCRC m…
28 views4 weeks ago
FacebookOncLive
Significant survival gains with atezolizumab for NSCLC
620 viewsJan 13, 2017
YouTubeecancer
The FDA Approval of Atezolizumab in Bladder Cancer | OncLive
Jul 6, 2016
onclive.com
IMpassion131: No Benefit for Atezolizumab Plus Paclitaxel in Tri…
Oct 9, 2020
ascopost.com
ASCO 2021 Lung Recap: IMpower010: Atezolizumab after C…
679 viewsJan 15, 2022
YouTubeGlobal Resource for Advancing Cancer Education
Atezolizumab/Bevacizumab for HCC: Toxicity Management | Targ…
Nov 5, 2020
targetedonc.com
See more videos
Static thumbnail place holder